Justin West is a physician and father of three. His youngest son, Andrew, was diagnosed with KCNT1-related epilepsy at 9 months of age. He is director of clinical medicine at the KCNT1 Epilepsy Foundation, working with researchers and industry to identify and evaluate potential therapeutics.
Justin West
President and director of clinical medicine
KCNT1 Epilepsy Foundation
From this contributor
Progress amid setbacks in drug trials for rare forms of epilepsy: Q&A with Justin West
Despite grave side effects, it’s vital to keep developing treatments for rare genetic forms of childhood epilepsy, says West, president of the KCNT1 Epilepsy Foundation and father of a son with the condition.
Progress amid setbacks in drug trials for rare forms of epilepsy: Q&A with Justin West
By
Calli McMurray
30 August 2023 | 6 min read
Explore more from The Transmitter
Neuroscientists weigh in on White House proposal for ‘moonshot infrastructure’ for connectomics
A report from the Trump administration calls for a “new golden age” of science, in which the federal government supports mission-driven collaborations to deliver high returns on research investments.
Neuroscientists weigh in on White House proposal for ‘moonshot infrastructure’ for connectomics
A report from the Trump administration calls for a “new golden age” of science, in which the federal government supports mission-driven collaborations to deliver high returns on research investments.
By
Sarah Thau
24 July 2026 | 4 min read
In memoriam: Kevin Dunbar, who traced the neural basis of human reasoning
Using imaging technologies, he transformed our understanding of how creativity and scientific discovery arise in the brain.
In memoriam: Kevin Dunbar, who traced the neural basis of human reasoning
Using imaging technologies, he transformed our understanding of how creativity and scientific discovery arise in the brain.
By
Alissa de Chassey
24 July 2026 | 6 min read
Neurons engage in risky, DNA-breaking business during migration
The cells later repair the damage, which occurs mostly in transcriptionally silent parts of the genome.
Neurons engage in risky, DNA-breaking business during migration
The cells later repair the damage, which occurs mostly in transcriptionally silent parts of the genome.
By
Sarah Thau
24 July 2026 | 4 min read